A Phase IIa Study to Evaluate NBQ72S

Inclusion criteria

• ✓. Absolute neutrophil count (ANC) ≥1,500/mm³ or ≥1.5 x 10⁹/L;
• ✓. Platelet count ≥100,000/mm³ or ≥100 x 10⁹/L;
• ✓. Hemoglobin ≥9 g/dL;
• ✓. Total serum bilirubin ≤1.5 x ULN; if the tumor involves the liver, or if the patient has a history of Gilbert's syndrome, total bilirubin must be \<3 x ULN;
• ✓. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤2.5 x ULN; if the tumor involves the liver, these values must be ≤5.0 x ULN;